• +264 813814414
  • info@consultfasz.com

In January 2023, the media reported that the Central Procurement Board of Namibia (the Board) awarded a procurement of N$650 million for the supply and delivery of clinical products to a newly formed company that quoted way above the next highest bidder. This led to a huge public outcry. The Board held a press conference
on 20 January 2023 and released a statement on 3 February 2023. During the press conference, the Board explained that the selected bidder was given an advantage as a local manufacturer as indicated on the bidding documents submitted. The Board further clarified in its . . .

Dear user, unfortunately you are not allowed to view this restricted content.
Please Login or Register in order to view.

error: Content is protected !!